A water extract of Samchulkunbi-tang attenuates airway inflammation by inhibiting inos and MMP-9 activities in an ovalbumin-induced murine asthma model
Open Access
- 17 December 2012
- journal article
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 12 (1) , 1-11
Abstract
Background: In this study, we investigated the effect of Samchulkunbi-tang water extract (SCTE) in an established mouse model of ovalbumin (OVA)-induced allergic asthma. The effects of SCTE on the production of Th1 and Th2 cytokines, eotaxin, and total and OVA-specific immunoglobulin E, inducible nitric oxide synthase expression, and matrix metalloproteinase-9 activity were measured. Methods: Mice were sensitized on days 0 and 14 with an intraperitoneal injection of 20 μg ovalbumin (OVA) emulsified in 2 mg aluminum hydroxide in 200 μL PBS buffer. On days 21, 22, and 23, mice received an airway exposure to OVA (1%, w/v, in PBS) for 1 h. SCTE was administered orally to mice at doses of 200 and 400 mg/kg per day from days 18 to 23. Results: SCTE reduced the number of inflammatory cells, cytokines, and chemokines in bronchoalveolar lavage fluids and iNOS expression and MMP-9 activity in mouse lung tissue. Histological studies using hematoxylin & eosin and periodic acid-schiff staining showed that SCTE substantially inhibited OVA-induced inflammatory cell infiltration in lung tissue and goblet cell hyperplasia in the airway. SCTE also reduced IL-4 and IL-13 expression in concanavalin-A-stimulated splenocytes. These results were similar to those obtained with montelukast as a positive control. Conclusions: Collectively, these results suggest that SCTE may be an effective oral treatment for allergic airway inflammation by virtue of its anti-inflammatory activity.Keywords
This publication has 30 references indexed in Scilit:
- Serum IL-33 but not ST2 level is elevated in intermittent allergic rhinitis and is a marker of the disease severityInflammation Research, 2012
- Interleukin-33 in Asthma: How Big of a Role Does It Play?Current Allergy and Asthma Reports, 2010
- A novel IL-1 family cytokine, IL-33, potently activates human eosinophilsJournal of Allergy and Clinical Immunology, 2008
- Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cellsCytokine, 2007
- IL‐33 is a chemoattractant for human Th2 cellsEuropean Journal of Immunology, 2007
- Anti-inflammatory Potential of Flavonoid Contents from Dried Fruit of Crataegus pinnatifida in Vitro and in VivoJournal of Agricultural and Food Chemistry, 2004
- Cytokine‐regulated accumulation of eosinophils in inflammatory diseaseAllergy, 2004
- Asthma: Mechanisms of Disease Persistence and ProgressionAnnual Review of Immunology, 2004
- Targeted Inactivation of the IL-4 Receptor α Chain I4R Motif Promotes Allergic Airway InflammationJournal of Experimental Medicine, 2003
- Allergen‐induced airway inflammation and bronchial responsiveness in interleukin‐5 receptor α chain‐deficient miceClinical & Experimental Allergy, 2000